In addition, the male:female ratio was confirmed to be different in MEN1 PHPT vs. sPHPT, with a significantly higher prevalence of affected women in sPHPT (93.6% of cases in our series) compared to MEN1 PHPT (65.4% of cases). This evidence concerns the gene MEN1 and multiple endocrine neoplasia type 1.